Executive Summary

There are two separate drug pricing application processes for drugs with or without an appropriate comparator. Japan also applies international reference pricing mechanisms and awards price premiums for several different reasons, including the level of innovation, paediatric use, market size etc. Drug prices are reviewed every two years, resulting in 5-10% average drug price cuts. Drugs reimbursed to hospitals and pharmacies are listed in the National Health Insurance Drug Price List.